Anti-Amyloid Alzheimer's Drugs Show Trivial Cognitive Benefit With Real Brain Bleed Risk
A Cochrane meta-analysis of 17 RCTs finds amyloid-targeting antibodies offer minimal cognitive gains while significantly raising ARIA risk.
10 articles
A Cochrane meta-analysis of 17 RCTs finds amyloid-targeting antibodies offer minimal cognitive gains while significantly raising ARIA risk.
A landmark review argues neurodegeneration is driven by interacting misfolded proteins, not single culprits โ reshaping diagnosis and treatment.
A landmark review reframes astrocytes as multilayered processing units that regulate synapses, circuits, and brain function at multiple spatial scales.
An expert panel maps the pathways linking urban greenspace to Alzheimer's risk and offers researchers a standardized measurement playbook.
A narrative review reveals India's unique dementia risk profile โ and why Western findings may not apply to 1.4 billion people.
A Cochrane meta-analysis of 8 RCTs finds most pharmacological treatments fail to improve ataxia scores, though upper limb dexterity may benefit.
A Cochrane review of two RCTs finds very low-certainty evidence that IGF-1 neither prevents nor worsens retinopathy of prematurity in extremely preterm infants.
A Lancet review reveals stroke pathways fail to adequately address frailty, disability, and comorbidity โ gaps with major consequences for older patients.
A new framework warns that AI tools used too early in medical education may prevent trainees from developing core clinical reasoning skills.
A major Lancet review argues that optimizing current depression treatments may be more impactful than developing new ones.